New dengue drug trial aims to shorten illness
NCT ID NCT07576868
First seen May 13, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study tests a new medicine called CP-COV03 for people with dengue fever. The goal is to see if it is safe and can help reduce symptoms and lower the amount of virus in the blood. About 210 adults with dengue will take the drug or a placebo. The trial is currently recruiting participants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The National Hospital of Tropical Diseases (NHTD)
NOT_YET_RECRUITINGHanoi, Vietnam
-
Tien Giang Provincial General Hospital
RECRUITINGMỹ Tho, Vietnam
Conditions
Explore the condition pages connected to this study.